Introduction to atrial fibrillation and heart failure: A mutually noxious association

Europace

Volumn 5, Issue SUPPL. 1, 2004, Pages

  Daubert, Jean Claude ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Atrial fibrillation; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN;

ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CLINICAL OBSERVATION; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CYCLE; HEART DISEASE; HUMAN; INCIDENCE; LONG TERM CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TACHYCARDIA INDUCED CARDIOMYOPATHY; TREATMENT INDICATION;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; HEART FAILURE, CONGESTIVE; HUMANS; PREVALENCE;

EID: 4444327198     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2004.07.002     Document Type: Editorial

References (19)

1. Benjamin E.J. Levy D. Vaziri S.M. D'Agostino R.B. Belanger A.J. Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort The Framingham Heart Study. JAMA 271 1994 840-844
2. Maisel W.H. Stevenson L.W. Atrial fibrillation in heart failure Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91 2003 2D-8D.
3. Waldo A.L. Mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 14 2003 S267-S274.
4. Dries D.L. Exner D.V. Gersh B.J. et al. Atrial fibrillation is associated with an increased risk for mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction A retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32 1998 695-703.
5. Maggioni A.P. Latini R. Negri M. et al. for the Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT trial Circulation 108 2003 507-508 [abstract].
6. Wang T.J. Larson M.G. Levy D. et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality The Framingham Heart Study Circulation 107 2003 2920-2925.
7. Baldasseroni S. Opasisch C. Giorni M. et al. Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure. Am Heart J 143 2002 398-405.
8. Baldasseroni S. De Biase L. Fresco C. et al. Italian Network on Congestive Heart Failure Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J 23 2003 1692-1698.
9. Gillette P.C. Smith R.T. Garson Jr. A. et al. Chronic supraventricular trachycardia A curable cause of congestive cardiomyopathy. JAMA 253 1985 391-392.
10. Shinbane J.S. Wood M.A. Jensen D.N. Ellenbogen K.A. Fitzpatrick A.P. Scheinman M.M. Tachycardia-induced cardiomyopathy A review of animal models and clinical studies. J Am Coll Cardiol 29 1997 709-715.
11. Al-Khatib S.M. Shaw L. Shah M. O'Connor C. Califf R.M. Atrial fibrillation in congestive heart failure Is rhythm control therapy superior to rate control therapy? Circulation 108 Suppl. IV 2003 471 [abstract].
12. Hagens V.E. Crijns H.J.G.M. Tijssen J.G.P. et al. Rate control versus electrical cardioversion for persistent atrial fibrillation in patients with heart failure Results of the RACE study. Eur Heart J 2003 24 [abstract]
13. Flaker C.C. Fletcher K.A. Rothbart R.M. Halperin J.L. Hart R.G. Clinical and echocardiographic features of intemittent atrial fibrillation that predict recurrent atrial fibrillation Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 144 2002 597-607.
14. Daubert C. Mabo P. Berder V. Gras D. Leclerq C. Atrial tachyarrhythmias associated with a high degree of interatrial conduction block Prevention by permanent atrial resynchronization. J Cardiovasc Electrophysiol 4 1994 35-44.
15. D'Allonnes G.R. Pavin D. Leclerq C. et al. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tacharrhythmia A nine-year experience. J Cardiovasc Electrophysiol 11 2000 2081-91.
16. Saksena S. Prakash A. Ziegler P. et al. DAPPAF Investigators Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 40 2002 1140-1150.
17. Wilkoff B.L. Cook J.R. Epstein A.E. et al. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002 288 3115-23
18. Victor F. Mansour H. Pavin D. et al. In search of the optimal ventricular pacing site: a randomized comparison of septal and conventional apical pacing. Eur Heart J 2003 24-46 [abstract]
19. Leclercq C. Walker S. Linde C. et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur. Heart J. 2002 23 1780-1787